News
Novartis to invest $23B in US manufacturing
Novartis plans to invest $23 billion over the next five years to expand its manufacturing and research in the U.S. The investment will cover more than 10 facilities, including seven new sites, and will enable the drugmaker to produce its key medicines for the U.
A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 ...
The pharmaceutical company says it will continue to operate its production facility near Research Triangle Park.
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...
Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.
The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...
The Swiss pharmaceutical giant plans to build seven new facilities and expand others in an effort that will allow it to ...
Shares in Swiss drugmaker Novartis (NVS) were looking perkier today as it set out plans to invest $23 billion in U.S. manufacturing to beat the ...
Morgan Stanley (MS), and Wells Fargo (WFC) are expected to r ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback